Get in Touch

Let’s Discuss Us

    coimbatore

    Frequently Asked Questions

    1. What types of cancer do you treat at Coimbatore Cancer Clinic?

    We provide diagnosis and treatment for all major cancers — including breast, lung, liver, colon, prostate, gynecologic, head & neck, hematologic (blood cancers), and rare tumours. Our expertise spans both solid and blood cancers, with personalized plans for each patient.

    No referral is needed. You can book an appointment directly by phone or through our online appointment form.

    We are open Monday to Saturday: 6:00 PM – 9:00 PM. Appointments can be scheduled in advance for consultations, follow-ups, and treatment planning.

    Most cases yield predictive results within 10–14 days using integrated IHC + NGS.

    We provide comprehensive diagnostics including: Imaging (CT, MRI, PET-CT) Biopsy and Histopathology Molecular profiling (NGS) Genetic and biomarker testing (BRCA, EGFR, ALK, PD-L1, MSI) Blood-based tumour marker analysis This allows accurate diagnosis and precise treatment selection.

    Yes. We provide genetic counselling and testing for hereditary cancers such as breast, ovarian, colon, and endometrial cancers. Early identification of at-risk individuals helps with targeted prevention, screening, and family counselling.

    Yes—if detected early and completely removed. Many others can be kept under long-term control with PRRT and targeted drugs.

    Our clinic offers comprehensive cancer care including: Chemotherapy Immunotherapy Targeted Therapy Hormonal Therapy CAR-T Cell Therapy (through partner centers) Bispecific T-cell Engager (BiTE) Therapy Radiation Therapy Coordination Advanced surgeries for Cancer Laparascopic surgery Robotic surgery VATS- thoracic/lung surgery Breast Oncoplasty Cytoreductive surgery and HIPEC

    Each case is reviewed by a multidisciplinary tumour board consisting of medical, surgical, and radiation oncologists. Treatment is tailored based on stage, molecular profile, patient health, and personal preferences.

    Yes. We frequently continue or optimize ongoing treatments for patients who have relocated or want a second opinion on their therapy plan or side-effect management.

    11. Do you offer second opinions?

    Yes. We offer detailed second-opinion consultations, where we review your existing reports and guide you on the best global-standard options for your specific diagnosis.

    Yes — certain subsets (axillary-node breast-type, squamous neck-node, peritoneal adenocarcinoma) are potentially curable when treated like their presumed origin.

    Absolutely. We emphasize comprehensive pain and symptom control using medications, nerve blocks, and supportive therapies. Our goal is to ensure every patient is treated with comfort, dignity, and respect.

    Yes. Our clinic provides psychological counselling and emotional support for patients and caregivers. We also help connect families to support groups and rehabilitation programs.

    Yes. Our nutrition team provides personalized diet plans to support recovery, reduce side effects, and maintain strength during treatment. We also advise on exercise, sleep, and stress management.

    Yes. We offer palliative care services focused on comfort, symptom control, and emotional well-being. Our approach emphasizes compassion, dignity, and holistic support for patients and families.

    Please bring: All previous medical records Biopsy or histopathology reports Imaging (CT, MRI, PET-CT) Blood test results Current medications and allergy list Insurance details (if applicable) This ensures a complete and efficient evaluation.

    A first consultation usually lasts 30–45 minutes, allowing enough time for discussion of your medical history, reports, and treatment options. Follow-ups typically take 15–20 minutes.

    Yes. We assist international and NRI patients with remote consultations, medical documentation, and local coordination for treatment in India.

    Treatment now depends on molecular identity rather than physical origin; with precision therapy, control rates approach site-specific cancers.